CPESN Northeast Tennessee pharmacies last year completed more than 3,500 combined flu (1,175) and fall (2,374) risk assessments for Emergent ACO patients. Rebecca Wagers, Managing Network Facilitator, says the assessments are much more than a means of learning whether a patient had a flu immunization or a recent fall. Watch this short video to see how pharmacies use the assessments to improve patient health and safety.

CPESN® Mississippi network pharmacies reported more than 200 encounters with 97 Medicaid plan members over just seven months. Pharmacies enrolled plan-identified asthma, ADHD, and diabetes patients in Med Sync programs and worked with health providers to drive follow up. The 2025 contract renewal is now expanding to include COPD patients.

Jenna Eccles, pharmacist/owner at Wheatridge Professional Pharmacy in Denver, describes how integrating RxE2 clinical study program steps to overall pharmacy workflow increases efficiency, patient engagement, and pharmacy non-dispensing revenue. Eccles, who is also the Managing Network Facilitator for CPESN Colorado, says having a program champion encourages pharmacies to tap into the opportunity.

Pharmacist Allysa Mack with Gibbs Pharmacy in Lebanon, TN describes how involving a Commiunity Health Worker in patient outreach for health risk assessments has increased profit for the pharmacy, and is improving care for patients.

Shannon Schultz, owner and lead pharmacist at Nebraska LTC Pharmacy, says an invitation to provide COVID vaccines to patients at the Dialysis Center of Lincoln was a success for the pharmacy, the patients, and the nonprofit. The Lincoln clinic shared its positive experience with CPESN Nebraska pharmacy with other members of the American Society of Nephrology. That groups Kidney Community Vaccination Collaborative is exploring with CPESN Health Equity an opportunity to expand the partnership model. Watch the short video to learn more.

The Elevance/Carelon Medicaid program makes it easier to postively impact patient health, says Dustin Williams, phamacy manager at Tru-Valu Drugs in Sanford, Florida. He shares an outcomes story about a patient who lowered her A1c level from 11 to 9.7 in three months.

A second two-year renewal of a medication review program for older adults is the result of CPESN Hawaii's strong overall network performance, says Dayna Wong-Otis, Managing Network Facilitator, The renewal with Hawaii Medical Services Association (HMSA) includes increases in case rates and in the network administration fees.

CPESN has been named a 2024 Health Quality Innovator of the Year, an annual award presented by Health Quality Innovators (HQI). CPESN partnered with HQI in 2024 to address vaccine hesitancy and improve access in Kansas, Missouri, South Carolina and Virginia. Trained pharmacy teams leveraged community trust to provide education, increase vaccinations and close care gaps. From September 25 to October 30, 2024, 279 clinics administered 12,795 immunizations, saving over $59M in healthcare costs. Each vaccine saved $4,000 in healthcare spending, underscoring the role of pharmacy teams in improving public health.

The expanded UnitedHealthcare Pharmacy Care Hub Program benefits rural patients, and others who may lack transportation or broadband internet service by allowing them to access telehealth visits from CPESN pharmacy locations.The program is currently available to UHC Community Plan members through CPESN pharmacies in Kansas, Virginia, North Carolina, and Florida. Alison Haas, CPESN Director of Value Based Contracting, says the program also allows pharmacy-led services including testing and treatment for minor illness, strep, or flu; as welll as MTM and patient education.

Andrew Wagner, pharmacist and owner at Eagle Grove Pharmacy, says he has seen a lot of different patient needs presented at the rural Iowa pharmacy. But a patient with a painful zip tie stuck on his tooth was a new one. Watch this short video to see how the Eagle Grove staff drew on CPESN training and a "patient first" attitutde for a positive and cost-effective patient outcome,